Sandoz ACA Violation Unlikely In Amgen Suit, Judge Says
A California federal judge said Friday he's unlikely to rule that Sandoz Inc. flouted the Affordable Care Act by failing to notify Amgen Inc. of its biosimilar version of a blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article